PPC:ATHEXPublic Power Corporation S.A. Analysis
Data as of 2026-03-14 - not real-time
$36.23
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Pilgrim's Pride is trading at $36.23, below its 52‑week high of $56.73 but above the DCF‑derived fair value of $30.20, indicating a modest overvaluation on a price basis. Technical indicators are mixed: the 20‑day SMA ($40.92) and 50‑day SMA ($41.31) sit well above the current price, the 14‑day RSI is at 26.3 % (oversold), and the MACD shows a bearish divergence. Fundamentally, the company posted a 3.3 % revenue growth year‑over‑year, a solid gross margin of 12.7 %, and a healthy ROE of 27 %, yet it carries a high debt‑to‑equity ratio of 90.8 % and generates no dividend. Recent earnings released this week beat revenue expectations but missed EPS consensus, contributing to short‑term price pressure. The stock’s beta (≈0.2) suggests low market‑wide volatility, but the 30‑day price volatility of over 30 % signals significant company‑specific swings. Analyst consensus remains a “hold” with a median target price of $43.5, implying roughly 20 % upside from current levels. Given the blend of oversold momentum, strong cash flow, and elevated leverage, investors should weigh short‑term downside risk against medium‑term upside potential.
Overall, the market’s current pricing reflects a cautious stance amid earnings miss and debt concerns, but the underlying business fundamentals and sector stability provide a foundation for a potential rebound, especially if the company can improve earnings per share and manage its leverage.
Overall, the market’s current pricing reflects a cautious stance amid earnings miss and debt concerns, but the underlying business fundamentals and sector stability provide a foundation for a potential rebound, especially if the company can improve earnings per share and manage its leverage.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD and price below short‑term moving averages
- RSI in oversold territory suggesting limited near‑term upside
- Recent earnings miss on EPS despite revenue beat
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Target median price of $43.5 implies ~20% upside
- Strong cash flow generation and solid ROE
- Low beta and defensive consumer sector support stability
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable demand for protein products in a defensive industry
- High debt‑to‑equity ratio poses leverage risk over time
- Absence of dividend reduces income‑focused appeal
Key Metrics & Analysis
Financial Health
Revenue Growth3.30%
Profit Margin5.85%
P/E Ratio8.0
ROE27.26%
ROA10.77%
Debt/Equity90.78
P/B Ratio2.3
Op. Cash Flow$1.4B
Free Cash Flow$630.9M
Technical Analysis
TrendBearish
RSI26.3
Support$35.79
Resistance$44.00
MA 20$40.92
MA 50$41.31
MA 200$42.30
MACDBearish
VolumeStable
Fear & Greed Index72.88
Valuation
Fair Value$30.20
Target Price$44.38
Upside/Downside22.50%
GradeOvervalued
TypeValue
Risk Assessment
Beta0.19
Volatility30.49%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.